EUROIMMUN Logo
Find
X

What are you looking for?

Filter for products in our complete portfolio

Product finder

Worldwide
X
EUROIMMUN worldwide

This website provides an overview of the business activities and products of EUROIMMUN AG worldwide. Not all products are registered and approved in all countries or regions. Please contact your country representative for product availability and information

EUROIMMUN branches

Choose your country

Europe

North America

South & Central America

Asia

Middle East & Africa

EUROIMMUN Logo
Español
Português

Chikungunya diagnostics

To date, approximately 350,000 cases of chikungunya virus infection and over 140 associated deaths have been reported in 20241.

According to the WHO, chikungunya virus is present in over 110 countries and about 4 billion people worldwide are at risk of infection 2.

Although the disease reveals a very low case fatality rate of less than 1%, a significant number of patients develop long-lasting or even chronic joint pain, similar to arthritis, which has a severe impact on the patient’s quality of life3.

Apart from joint pain, chikungunya virus infection causes very similar symptoms to dengue and Zika, which is why it is often misdiagnosed2.

1 ECDC: Chikungunya worldwide overview, situation update as of 31 of July 2024
2 WHO: Chikungunya fact sheet as of 08 of December 2022
3 WHO: Chikungunya virus disease outbreak, situation update as of 03 of May 2023

Infection diagnostics with EUROIMMUN

As chikungunya virus causes febrile diseases with similar symptoms to other arboviruses, our test portfolio includes several assays to support reliable diagnostics of chikungunya virus infection and provide differentiation from dengue and Zika virus infections.

Other relevant arboviral parameters:

Dengue        Zika

Thinking globally – Acting locally
With over 35 years of experience in the field of laboratory diagnostics, we develop and globally distribute complete diagnostic solutions that are tailored to your local needs.

Working together with local health and scientific authorities we stay aware of novel and/or urgent infection events and provide appropriate solutions for infectious diseases diagnostics all over the world. With our unrivalled in-house development and production of diagnostic test systems as well as our automation and software solutions, we are able to respond rapidly to both small and large infection outbreaks, providing support national and international health entities when and where it is needed.
Thinking globally – acting locally

Important for differential diagnostics of arboviral fever diseases

ELISA

Indirect immunofluorescence assay

  • Anti-Chikungunya virus IIFT (IgM, IgG)
    → Data sheet (PDF)
  • Arbovirus fever mosaic 2 (IgG, IgM)
    → Data sheet (PDF)
  • Arbovirus Profil 3 (IgG, IgM)
    Order no. FI 293a-1005 G / M, FI 2668-1005-1 G / M, FI 2668-1005-3 G / M

Find out more about our test portfolio

Emerging diseases

 
 

EUROIMMUN's solutions for arboviral infections

in the Americas

 
 

More information

Contact

If you have any questions, please do not hesitate to contact us:

Product Management Infection Diagnostics

infection-pm(at)euroimmun.de

Or get in touch with your local contact person

Find your local distributor

Editorial: Innovations for infectious diseases diagnostics

EUROIMMUN offers an extensive range of test systems for infection diagnostics, including serological
assays for antibody determination and PCR-based tests for direct pathogen detection. For the growing
field of emerging diseases, EUROIMMUN boasts one of the largest portfolios of antibody tests
worldwide to support diagnosis and surveillance of upsurging viral and parasitic infections.
Read more

Featured in PPC, April 2024

Editorial: Serological differentiation of Zika from dengue virus infections

SEROLOGICAL DIAGNOSIS OF ZIKA virus (ZIKV) infections is challenging due to the high cross reactivity between flaviviruses. Test systems utilising virus-specific antigen can overcome this obstacle. A novel anti-ZIKV ELISA based on a highly specific antigen is devoid of cross reactivity with dengue virus (DENV) antibodies, and provides highly specific and sensitive ZIKV diagnostics.
Read more

Featured in MedLab Daily Dose, March 2017

 
Back to top
Contact person on site
Please click on a country or enter yours
North America
South & Central America
Europe
Asia
Oceania
Middle East & Africa